Pitavastatin (Livalo) - The Seventh Statin
The FDA has approved the marketing of pitavastatin (Livalo – Kowa), an HMG-CoA reductase inhibitor
(“statin”), for treatment of primary hyperlipidemia or mixed dyslipidemia. It has been available in Japan
since 2003. All of the statins now available in the US are listed in the table on page 58....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Pitavastatin (Livalo) - The Seventh Statin
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1343
Article Code: 1343a
Date: July 26, 2010
Volume: 52
Pages: 59-58
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1343
Article Code: 1343a
Date: July 26, 2010
Volume: 52
Pages: 59-58
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)